Abstract: This study proposes a modified human immunodeficiency virus (HIV) infection differential equation model with a saturated infection rate. This model has an infection-free equilibrium point and an endemic infection equilibrium point. Using Lyapunov functions and LaSalle's invariance principle shows that if the model's basic reproductive number R 0 < 1, the infection-free equilibrium point is globally asymptotically stable, otherwise the endemic infection equilibrium point is globally asymptotically stable. It is shown that a forward bifurcation will occur when R 0 = 1. The basic reproductive number R 0 of the modified model is independent of plasma total CD4 + T cell counts and thus the modified model is more reasonable than the original model proposed by Buonomo and Vargas-De-León. Based on the clinical data from HIV drug resistance database of Stanford University, using the proposed model simulates the dynamics of two group patients' anti-HIV infection treatments. The simulation results have shown that the first 4 weeks' treatments made the two group patients' R′ 0 < 1, respectively. After the period, drug resistance made the two group patients' R′ 0 > 1. The results explain why the two group patients' mean CD4 + T cell counts raised and mean HIV RNA levels declined in the first period, but contrary in the following weeks.
Introduction
According to human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) key facts updated by the World Health Organisation (WHO) on July 2014, HIV continues to be a major global public health issue, having claimed more than 39 million lives so far; there were ∼35 (33.1-37.2) million people living with HIV at the end of 2013; effective treatment with anti-retroviral drugs can control the virus so that people with HIV can enjoy healthy and productive lives [1] .
In the last decades, much work has been done on modelling and analysing the dynamics of HIV infection [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . A basic mathematical model of HIV infection widely used has the following form [2, 4-6]
where x(t), y(t) and v(t) represent the concentrations of uninfected CD4 + T cells, infected CD4 + T cells and free virus (HIV), respectively. Uninfected CD4 + T cells are produced at a natural rate l, die at rate d 1 x, and become infected at rate k 1 xv. Infected CD4 + T cells are produced at rate k 1 xv and die at rate d 2 y. Free virus (HIV) is produced from infected cells at rate ay and dies at rate d 3 v. In the basic model (1), CD4 + T cells in vivo are classified as two kinds: uninfected CD4 + T cells and infected CD4 + T cells. Recently, some mathematical models of HIV infection have been modified by considering three classes of CD4 + T cells: uninfected cells, infected cells in latent stage and productively infected cells [7, 9, 13] .
One of above mentioned modified models is a four-dimensional (4D) differential equation model proposed by Buonomo and Vargas-De-León [13] . This model has the following formẋ
where x(t), y(t), s(t) and v(t) represent the concentrations of uninfected CD4 + T cells, infected CD4 + T cells in latent stage, productively infected CD4 + T cells and free virus (HIV), respectively. Parameters l, d 1 , k 1 are the same as those in (1). Infected cells in latent stage die at rate d 2 y. k 2 y is the rate at which infected cells in latent stage become productively infected cells. And thus productively infected cells are produced at rate k 2 y and die at rate d 3 s.
As well explained in [7] , a proportion of infected cells in the eclipse stage can revert to the uninfected state before the viral genome is integrated into the genome of the lymphocyte. In (2), py is the rate at which the cells in latent phase may revert to the uninfected class. Free virus (HIV) is produced from the productively infected cells at rate as and dies at rate d 4 v.
Model (2) has a basic reproductive number [13] . Buonomo and Vargas-De-León have proved that if R 0 ≤ 1, the infection-free steady state is globally asymptotically stable; if R 0 > 1, the endemic steady state is globally asymptotically stable [13] .
In the basic reproductive number R 0 , l/d 1 represents the total number of uninfected CD4 + T cells in vivo. This implies that an individual with more uninfected CD4 + T cells will be more easily infected than an individual with less uninfected CD4 + T cells. The meaning of R 0 is biologically questionable.
Furthermore, the rate of HIV infection is assumed to be bilinear by the mass action term k 1 xv in (2). However, the actual incidence rate is probably not linear over the entire range of virus v and uninfected CD4 + T cells x [14] [15] [16] . Now let us to analyse some biological mechanisms on HIV infection and propose a modified HIV infection model. During primary HIV infection, the concentration of uninfected CD4 + T cells (x) is superabundant. An increase in x will not increase the rate of HIV infection. For this condition, the rate of HIV infection approximates k 1 v, a linear donordependent function. On the other hand, since the total number of healthy CD4 + T cells in vivo is limited, the HIV infection approaches to saturation with more and more virus produced and then the concentration of free virus (HIV), v, becomes superabundant. An increase in v will not increase the rate of HIV infection. For this condition, the rate of HIV infection approximates k 1 x, a linear donordependent function. Thus, it is reasonable to assume that the rate of HIV infection: the term −k 1 xv in Model (2) should be replaced by
We will show that the basic reproductive number R 0 of our modified model is independent of the total number of CD4 + T cells, and then present two theorems which state the conditions such that the infection-free equilibrium point and the endemic infection equilibrium point become globally attractive, respectively. As an application, the clinical data of two groups of patients' anti-HIV infection treatment from an HIV drug resistance database of Stanford University [19] are used to determine the model's parameter values and implement numerical simulations.
The rest of this paper is organised as follows: Section 2 introduces the modified HIV infection model and discusses the bondedness of the solution trajectories of the model. Sections 3 and 4 show the globally asymptotical stabilities of the infection-free state and the endemic infection state of the modified HIV infection model, respectively. Section 5 analyses the bifurcation of the modified model, draws the bifurcation diagram and simulations the dynamics of two group patients' anti-HIV infection therapies. Section 6 gives conclusions.
HIV infection model

Modified model
On the basis of (2), this paper introduces a modified model as follows. The model considers a saturated infection rate k 1 xv/ (x+v) to overcome the biological question of the basic reproductive number. Indeed, some latently infected T cells will not become activated and instead revert back to a resting state similar to a memory T cell state carrying an integrated provirus and capable of resuming virus production in blood after reactivation [17] . It suggests that infected CD4 + T cells in latent stage are able to resume producing new virus even if at resting state. Hence, the proportion of resting infected CD4 + T cells reverting to the uninfected state will be ignored in this model. The modified HIV infection model has the following forṁ
where the variables x(t), y(t), s(t) and v(t) represent the same meanings as those described in (2). The parameters l, 
which is independent of the total number of uninfected CD4 + T cells in vivo. If R 0 ≤ 1, then the uninfected steady state
is the unique steady state. Q 1 is called infection-free equilibrium point. If R 0 > 1, then in addition to the uninfected steady state, there is only one endemic infected steady state
Q 2 is called endemic infection equilibrium point. Here
Boundedness of solutions
It is easy to show that the solutions of (3) with initial condition x(0) > 0, y(0) > 0, s(0) > 0, v(0) > 0 have all positive components for t > 0. Hence, one begins the analysis of (3) by observing the non-negative octant Let
The derivative of C(t) along the positive solution of (3) iṡ
, and then C(t) = x(t) + y(t) + s(t) ≤ l/d. Therefore x(t), y(t) and s(t) are bonded.
From the last equation of (3), one obtainṡ
Hence there is a bounded subset of D
such that any solution trajectory (x(t), y(t), s(t), v(t)) of (3) with initial value (x(0),
3 Stability of the infection-free equilibrium point Q 1
In this section, it will analyse locally asymptotical stability and globally asymptotical stability of the infection-free equilibrium point Q 1 of (3) via using the Routh-Hurwitz criterion and the LaSalle's invariance principle.
Locally asymptotical stability of the infection-free equilibrium point Q 1
Theorem 1: (3) is locally asymptotically stable.
Proof: The Jacobi matrix of (3) has the form
where
. Hence substituting the equilibrium point Q 1 into (9) gives
and the corresponding eigenequation is
and
Equation (11) can be written as
Hence a 1 > 0, a 2 > 0, a 1 a 2 − a 3 > 0. If R 0 < 1, then a 3 > 0. All inequalities of the Routh-Hurwitz criterion are satisfied. Therefore, the equilibrium point Q 1 is locally asymptotically stable. □
Globally asymptotical stability of the infection-free equilibrium Q 1
Theorem 2: If R 0 < 1, the infection-free equilibrium point Q 1 of (3) is globally asymptotically stable in Ω.
Proof: Define a global Lyapunov function by
The derivative of L 1 (x, y, s, v) along the positive solution of (3) is
Hence the largest compact invariant set in Ω is
According to the LaSalle's invariance principle, lim t→ + ∞ v(t) = 0. One can get limit equationṡ
Define a global Lyapunov function by
The derivative of L 2 (x, y, s) along the positive solutions of (12) is
Since the arithmetic mean is greater than or equal to the geometric mean, we obtain
= 0 if and only if x = x 0 , s = 0. There is the largest compact invariant set in E 1
In E 2 , from the third equation of (12), it can obtain k 2 y − d 3 × 0 = 0, and then y = 0. So
Hence if R 0 < 1, all solution trajectories in Ω approach the equilibrium point Q 1 . □ 4 Stability of the endemic infection equilibrium point Q 2
In this section, it will discuss the globally asymptotical stability of the endemic infection equilibrium point Q 2 of (3) via using the LaSalle's invariance principle.
Theorem 3: If R 0 > 1, the endemic infection equilibrium point Q 2 of (3) is globally asymptotically stable in Ω.
The derivative of V(x, y, s, v) along the positive solution of (3) isV
According to (7), if R 0 > 1, then the endemic infection www.ietdl.org equilibrium point Q 2 exists. At Q 2 , (3) can be written into
Hence, one obtains that
and thenV
According to the second equation of (13)
and then one haṡ
Since the arithmetic mean is greater than or equal to the geometric mean, one obtains
ThereforeV ≤ 0 holds in Ω. AndV = 0 when x = x, y = y, s = s, v = v. Hence the largest compact invariant subset in Ω is
Hence if R 0 > 1, then the equilibrium point Q 2 is globally asymptotically stable in Ω by the LaSalle's invariance principle. □
Numerical simulation
Background
The randomised study of anti-retroviral management based on plasma genotypic anti-retroviral resistance testing in HIV patients failing therapy was enrolled from 14 units of the Terry Beirn Community Programs for Clinical Research on AIDS and the Walter Reed Army Medical Center [18] . These patients were failing virologically on a combination anti-retroviral regimen containing protease inhibitors (PI) and nucleoside reverse transcriptase inhibitors (NRTI) [18] . During that study, the patients were seen at weeks 4, 8 and 12. At each follow-up visit, changes in anti-retroviral treatment were recorded and the tested items included patients' plasma CD4 + T cell counts and plasma HIV-1 RNA levels by the Chiron 2.0 bDNA assay [18] . The report and clinical data of the study above are provided by the HIV drug resistance database of Stanford University [19] .
This section simulates the evolution dynamics of two group patients' mean uninfected CD4 + T cell counts and mean HIV RNA levels. The two group patients were classified from the study above based on the kind of drugs they had taken. Group I consists of 8 patients; and Group II consists of 13 patients. The two group patients received the same PI: ritonavir and saquinavir. In addition, Group I received NRTI: dideoxyinosine (DDI). Group II received NRTI: strvudine (D4T) and DDI [18] .
Modelling
On the basis of (3), the anti-HIV infection treatment model has the formẋ
where m, n (0 ≤ m, n ≤ 1) are the efficacy parameters of the treatment. The basic reproductive number of (14) is
The infection-free steady-state solution Q 1 of (14) is the same as that defined by (5)
The endemic infection equilibrium point Q 2 of (14) is given by
Herẽ
First of all, determine the parameter value ranges of (14) (1) Naive CD4 + T cells decayed with an average half-life of 50 days [20] . Therefore one obtains 
(6) Referring [7] , one obtains
(7) Referring [23] , one can obtain the other parameter value ranges as follows
Next, one makes the bifurcation analysis and then using (14) simulates the mean dynamics of anti-HIV infection treatment of the two group patients. In these simulations, firstly determine the parameter values, secondly make numerical simulation via (14) and finally display and analyse the results of simulation. In Group II, there was one patient whose clinical data was not complete. Therefore we do not conclude this patient's clinical data in the following simulations.
Bifurcation analysis
According to [24] , if the basic reproductive number R 0 < 1, there is an asymptotically stable infection-free equilibrium point; if R 0 > 1, there is an asymptotically stable endemic infection equilibrium point, and thus there usually occurs forward bifurcation at R 0 = 1.
Theorem 2 has shown that if R 0 < 1, the infection-free equilibrium point Q 1 of (3) is globally asymptotically stable and Theorem 3 has shown that if R 0 > 1, the endemic infection equilibrium point Q 2 of (3) is globally asymptotically stable. Hence, the bifurcation of model (3) is forward, which means that a forward bifurcation occurs at R 0 = 1.
To draw the bifurcation diagram of the variable S (productively infected CD4 + T cells) with the change of R 0 , it considers k 1 as an independent variable and the other parameters as constants so that it determines a = 15 and d 4 = 0.3466. And then it can get the different values of R 0 with k 1 increasing.
On the basis of different values of R 0 , draw the bifurcation diagram of the forward bifurcation as shown in Fig. 1 .
Mean dynamics simulation of Group I's anti-HIV infection treatment
Using eight patients' clinical data determines the equation parameters as those listed in Table 1 , in which n and the basic reproductive number R 0 change at different weeks. The simulation results of the mean dynamics of Group I's anti-HIV infection treatment are shown in Fig. 2 . During the first 4 weeks, the treatment made the basic reproductive number R 0 have reduced from 10.8048 to 0.8601. Hence the patients' mean uninfected CD4 + T cell counts increased and mean HIV RNA levels decreased rapidly to approach to infection-free steady state Q 1 defined by (16) as Theorem 2 predicts.
However, after the fourth week, the resistance to anti-retroviral drugs appeared. The drug resistance made the treatment efficacy parameter n decrease from 0.92 to 0.895. The following treatment made R 0 value of Group I have increased from 0.8601 to 1.1288. As a result, the patients' mean uninfected CD4 + T cell counts tended to decrease; the patients' mean HIV RNA levels began increasing to converge to a new infected steady state Q 2 defined by (17) and (18) as Theorem 3 predicts.
Mean dynamics simulation of Group II's anti-HIV infection treatment
Using 12 patients' clinical data determines the equation parameters as those listed in Table 2 , in which n and the basic reproductive number R 0 change at different weeks.
The simulation results of the mean dynamics of Group II's anti-HIV infection treatment are shown in Fig. 3 . During the first 4 weeks, the treatment made the basic reproductive number R 0 have reduced from 10.8048 to 0.8171. Hence the patients' mean uninfected CD4 + T cell counts increased and mean HIV RNA levels decreased rapidly to approach to infection-free steady state Q 1 defined by (16) as Theorem 2 predicts.
However, after the fourth week, the resistance to anti-retroviral drugs appeared. The drug resistance made the treatment efficacy parameter n decrease from 0.924 to 0.892. The following treatment made R 0 value of Group II has increased from 0.8171 to 1.1611. As a result, the patients' mean uninfected CD4 + T cell counts increased more slowly than before and then began to decrease; the patients' mean HIV RNA levels began increasing to converge to a new infected steady state Q 2 defined by (17) and (18) as Theorem 3 predicts.
Furthermore, Theorem 2 has claimed that if R 0 < 1, then the infection-free equilibrium point Q 1 of (3) is globally asymptotically stable in Ω. The above simulation results also confirm that when a patient's R 0 < 1, the patient's HIV level will decrease to approach to infection-free steady state. Theorem 3 has claimed that if R 0 > 1, then the endemic infection equilibrium point Q 2 of (3) is globally asymptotically stable in Ω. The above simulation results also confirm that when a patient's R 0 > 1, the patient will be still at endemic infection steady state. Fig. 2 Outcomes of the treatment efficacy of Group I; circles: clinical data; solid line: numerical simulation of (14) a Mean uninfected CD4 + T cell counts b Mean HIV RNA levels 
Conclusions
On the basis of an HIV infection model in [13] , this paper considers a modified HIV infection model containing the saturated infection rate k 1 xv/(x+v). The basic reproductive number R 0 of the model is independent of plasma total CD4 + T cell counts l/d 1 . This suggests that our model is more reasonable than the model proposed by Buonomo and Vargas-De-León [13] .
Theorems 2 and 3 show the conditions such that the infection-free equilibrium point and the endemic infection equilibrium point become globally attractive. It is also shown that a forward bifurcation occurs when R 0 = 1. From the two theorems, one can conclude:
(1) If an infected person's basic reproductive number R 0 < 1, then the infection-free equilibrium point Q 1 of his/her infection (anti-infection therapy) model is globally asymptotically stable. This result suggests (a) if the person self's basic reproductive number is less than one, he/she can recover automatically even if infected with a large amount of virus; (b) if the person self's basic reproductive number is larger than one, but an anti-HIV treatment makes the infected person's basic reproductive number be less than one and no virus mutation or drug resistance appears, then the treatment will make the infected person be cured eventually.
(2) If an infected person's basic reproductive number R 0 > 1, then the endemic infection equilibrium point Q 2 of his/her infection (anti-infection therapy) model is globally asymptotically stable. This result suggests (a) if the infected person self's basic reproductive number is large than one, he/she will be endemic infected even if infected with tiny amount of virus; (b) if an anti-HIV treatment cannot make an infected person's basic reproductive number be less than one, then the treatment will never make the infected person be cured. This paper also simulates the dynamics of the two group patients' anti-HIV infection treatment. The simulation results suggest:
(1) Under some simplified assumptions, some parameters of the model have been determined. The simulation results are closed to the patients' mean CD4 + T cell counts and HIV RNA levels.
(2) The simulations confirm that the treatments made the patients' mean HIV RNA levels, reduce rapidly in the early weeks, because the patients' R′ 0 < 1. However, after week 4, the drug resistance made the basic reproductive number R′ 0 of the two groups be larger than one such that the two group patients' mean HIV RNA levels rebounded. The long-term treatment is necessary if the drug resistance would not become worse.
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